Cargando…
CD19 Alterations Emerging after CD19-Directed Immunotherapy Cause Retention of the Misfolded Protein in the Endoplasmic Reticulum
We previously described a mechanism of acquired resistance of B-cell acute lymphoblastic leukemia to CD19-directed chimeric antigen receptor T-cell (CART) immunotherapy. It was based on in-frame insertions in or skipping of CD19 exon 2. To distinguish between epitope loss and defects in surface loca...
Autores principales: | Bagashev, Asen, Sotillo, Elena, Tang, Chih-Hang Anthony, Black, Kathryn L., Perazzelli, Jessica, Seeholzer, Steven H., Argon, Yair, Barrett, David M., Grupp, Stephan A., Hu, Chih-Chi Andrew, Thomas-Tikhonenko, Andrei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Microbiology
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6189457/ https://www.ncbi.nlm.nih.gov/pubmed/30104252 http://dx.doi.org/10.1128/MCB.00383-18 |
Ejemplares similares
-
Retention of CD19 intron 2 contributes to CART-19 resistance in leukemias with subclonal frameshift mutations in CD19
por: Asnani, Mukta, et al.
Publicado: (2019) -
Characterization of Leukemic Resistance to CD19-Targeted CAR T-cell Therapy through Deep Genomic Sequencing
por: Chen, Gregory M., et al.
Publicado: (2023) -
Misfolding and aggregation of newly synthesized proteins in the endoplasmic reticulum
Publicado: (1992) -
The mechanisms to dispose of misfolded proteins in the endoplasmic reticulum of adipocytes
por: Wu, Shuangcheng Alivia, et al.
Publicado: (2023) -
Tay–Sachs disease mutations in HEXA target the α chain of hexosaminidase A to endoplasmic reticulum–associated degradation
por: Dersh, Devin, et al.
Publicado: (2016)